Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-20

Clinical Trial Update: BUSCLAB - Buscopan to Prevent Slow Progress in Labor [Phase 3]

View source ↗

Summary

Phase 3 trial investigating Buscopan (scopolamine butylbromide) to prevent slow progress in labor has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Buscopan (hyoscine butylbromide)

Snippet

Sponsor: Oslo University Hospital | Conditions: Labor (Obstetrics)--Complications, Labor; Prolonged, First Stage | Phase 3 | Status: COMPLETED